Drug Delivery in Cancer Treatment III

1. Front Matter

   Pages I-VIII

   PDF

2. Introduction

   • L. Domellöf

   Pages 1-2

3. Perspectives in Home Care

   • S. P. Israels, R. Dubbelman

   Pages 3-17

4. Symptom Control in Palliative Home Care

   • V. Ventafridda, A. Caraceni, L. Saita, A. Sbanotto, E. Spoldi, F. De Conno

   Pages 19-39

5. Long-Term and Home Parenteral Nutrition to Cancer Patients

   • K. G. Lundholm, A. Hyltander

   Pages 41-51

6. A Home-Care Project for Cancer Patients in Germany: Background and Experiences

   • S. Frohmüller, P. Schlag

   Pages 53-61

7. Economic Evaluation of Cancer Treatments

   • B. Jönsson, G. Karlsson

   Pages 63-84

8. Therapeutical Drug Monitoring of Anticancer Drugs

   • L. K. Paalzow

   Pages 85-96

9. Tumours in the Brain: A Special Case for Drug Delivery

   • Paul Workman

   Pages 97-125

10. Back Matter

    Pages 127-128

    PDF

The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach wh ich is difficult for the Univer­ sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monocional antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of oncology.

• Ernährung bei Krebspatienten
• Heimbehandlung
• Wirtschaftlichkeit
• cancer
• cancer therapy
• cancer treatment
• clinical research
• drug
• drug delivery
• drug design
• home care
• nutrition
• research
• tumor

• Department of Surgery, Örebro Medical Centre Hospital, Örebro, Sweden

  Lennart Domellöf

Policies and ethics